Sandfire Resources share price on watch after Tshukudu update

The Sandfire Resources Ltd (ASX:SFR) share price will be one to watch on Friday after the release of a positive exploration update…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sandfire Resources Ltd (ASX: SFR) share price could be on the move on Friday following the release of an exploration update.

What did Sandfire Resources announce?

This morning Sandfire Resources updated the market on the expanded exploration program which commenced towards the end of last year at its Tshukudu Exploration Project in the Kalahari Copper Belt in Botswana.

The Tshukudu Exploration Project comprises ~11,700km2 of highly prospective licences surrounding the company's T3 Copper-Silver Project. The latter project is currently progressing towards the development of its first copper-silver mine in Botswana.

According to the release, drilling activities taking place at the A4 Dome, which is approximately 8km west of the T3 Project, have returned encouraging results.

Drilling to date has intersected significant widths and grades of shallow, vein-hosted copper mineralisation along a 250m strike length, which remains open along strike and at depth.

Sandfire's managing director and CEO, Karl Simich, appeared to be very pleased with the drilling. He believes the results of the expanded exploration campaign are a testament to the scale of the exploration opportunity in the Kalahari Copper Belt.

Simich said: "For Sandfire to be able to report such encouraging results from the first holes into a newly discovered shallow zone of mineralisation so soon after the MOD acquisition clearly demonstrates the outstanding potential of this copper belt."

"While the A4 Dome is a high priority for us in the immediate future, there are a number of other compelling targets planned to be drilled along the belt in this accelerated program. Given its proximity to the T3 Project, we are ramping up the drilling with two additional rigs currently being sourced to scope out the potential of this exciting target," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »